Charles River Laboratories Pre-Tax Profit Margin 2010-2025 | CRL

Current and historical pre-tax profit margin for Charles River Laboratories (CRL) from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Charles River Laboratories pre-tax profit margin for the three months ending March 31, 2025 was .
Charles River Laboratories Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2025-03-31 $4.02B $0.03B 0.75%
2024-12-31 $4.05B $0.09B 2.30%
2024-09-30 $4.06B $0.52B 12.78%
2024-06-30 $4.08B $0.54B 13.27%
2024-03-31 $4.11B $0.55B 13.38%
2023-12-31 $4.13B $0.58B 14.10%
2023-09-30 $4.22B $0.62B 14.66%
2023-06-30 $4.18B $0.63B 15.03%
2023-03-31 $4.09B $0.64B 15.72%
2022-12-31 $3.98B $0.62B 15.67%
2022-09-30 $3.78B $0.54B 14.33%
2022-06-30 $3.69B $0.54B 14.70%
2022-03-31 $3.63B $0.53B 14.46%
2021-12-31 $3.54B $0.48B 13.56%
2021-09-30 $3.43B $0.49B 14.24%
2021-06-30 $3.27B $0.50B 15.27%
2021-03-31 $3.04B $0.46B 15.02%
2020-12-31 $2.92B $0.45B 15.25%
2020-09-30 $2.82B $0.38B 13.46%
2020-06-30 $2.75B $0.32B 11.57%
2020-03-31 $2.72B $0.29B 10.76%
2019-12-31 $2.62B $0.30B 11.59%
2019-09-30 $2.53B $0.27B 10.78%
2019-06-30 $2.45B $0.27B 11.14%
2019-03-31 $2.38B $0.28B 11.95%
2018-12-31 $2.27B $0.28B 12.40%
2018-09-30 $2.14B $0.28B 12.84%
2018-06-30 $2.02B $0.28B 13.61%
2018-03-31 $1.91B $0.28B 14.80%
2017-12-31 $1.86B $0.30B 15.99%
2017-09-30 $1.85B $0.29B 15.82%
2017-06-30 $1.81B $0.27B 15.04%
2017-03-31 $1.77B $0.25B 14.04%
2016-12-31 $1.68B $0.22B 13.26%
2016-09-30 $1.57B $0.21B 13.32%
2016-06-30 $1.49B $0.21B 14.01%
2016-03-31 $1.40B $0.22B 15.38%
2015-12-31 $1.36B $0.20B 14.31%
2015-09-30 $1.34B $0.19B 13.82%
2015-06-30 $1.32B $0.18B 13.35%
2015-03-31 $1.32B $0.17B 12.66%
2014-12-31 $1.30B $0.18B 13.71%
2014-09-30 $1.26B $0.16B 12.81%
2014-06-30 $1.22B $0.16B 13.10%
2014-03-31 $1.17B $0.15B 12.45%
2013-12-31 $1.17B $0.14B 11.93%
2013-09-30 $1.16B $0.14B 12.28%
2013-06-30 $1.14B $0.13B 11.11%
2013-03-31 $1.14B $0.13B 11.45%
2012-12-31 $1.13B $0.13B 11.42%
2012-09-30 $1.14B $0.14B 11.92%
2012-06-30 $1.14B $0.13B 11.67%
2012-03-31 $1.14B $0.14B 11.90%
2011-12-31 $1.14B $0.13B 11.72%
2011-09-30 $1.13B $-0.27B -23.99%
2011-06-30 $1.13B $-0.31B -27.06%
2011-03-31 $1.13B $-0.33B -28.90%
2010-12-31 $1.13B $-0.34B -29.54%
2010-09-30 $1.12B $0.07B 6.00%
2010-06-30 $1.14B $0.12B 10.07%
2010-03-31 $1.16B $0.14B 12.06%
2009-12-31 $1.17B $0.15B 12.89%
Sector Industry Market Cap Revenue
Medical Medical Services $7.452B $4.050B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $141.373B 26.51
Elevance Health (ELV) United States $87.880B 11.34
CVS Health (CVS) United States $87.261B 10.85
Cencora (COR) United States $58.118B 20.22
Natera (NTRA) United States $23.068B 0.00
DiDi Global (DIDIY) China $23.062B 24.50
Labcorp Holdings (LH) United States $21.972B 17.82
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.845B 0.00
Solventum (SOLV) United States $13.121B 13.89
CochLear (CHEOY) Australia $12.902B 0.00
ICON (ICLR) Ireland $11.746B 10.92
Revvity (RVTY) United States $11.400B 19.62
Viatris (VTRS) United States $10.481B 3.60
Avantor (AVTR) United States $9.172B 13.33
HealthEquity (HQY) United States $9.059B 39.68
Medpace Holdings (MEDP) United States $9.021B 23.96
Sonic Healthcare (SKHHY) Australia $8.561B 0.00
Caris Life Sciences,�Inc (CAI) $6.798B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.602B 27.10
BrightSpring Health Services (BTSG) United States $4.147B 38.05
Sotera Health (SHC) United States $3.156B 17.93
Surgery Partners (SGRY) United States $2.849B 37.05
Alignment Healthcare (ALHC) United States $2.770B 0.00
Concentras Parent (CON) United States $2.637B 15.24
GeneDx Holdings (WGS) United States $2.634B 101.44
Organon (OGN) United States $2.516B 2.67
PACS (PACS) United States $1.969B 0.00
Ardent Health (ARDT) United States $1.954B 8.33
Progyny (PGNY) United States $1.886B 41.51
Premier (PINC) United States $1.806B 13.71
GoodRx Holdings (GDRX) United States $1.779B 35.57
Teladoc Health (TDOC) United States $1.528B 0.00
Establishment Labs Holdings (ESTA) $1.235B 0.00
Pediatrix Medical (MD) United States $1.233B 9.38
CareDx (CDNA) United States $1.088B 16.99
Agilon Health (AGL) United States $0.952B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.919B 0.00
QDM (QDMI) Hong Kong, SAR China $0.840B 0.00
AMN Healthcare Services Inc (AMN) United States $0.791B 7.41
Nutex Health (NUTX) United States $0.692B 10.47
LifeMD (LFMD) United States $0.619B 0.00
Embecta (EMBC) United States $0.566B 3.82
InnovAge Holding (INNV) United States $0.498B 0.00
Enhabit (EHAB) United States $0.488B 40.17
SBC Medicals (SBC) United States $0.481B 0.00
Omada Health (OMDA) $0.471B 0.00
Sonida Senior Living (SNDA) United States $0.471B 0.00
Auna S.A (AUNA) Luxembourg $0.459B 10.33
So-Young (SY) China $0.314B 0.00
Performant Healthcare (PHLT) United States $0.313B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.262B 0.00
Beauty Health (SKIN) United States $0.241B 0.00
Oncology Institute (TOI) United States $0.183B 0.00
DocGo (DCGO) United States $0.160B 26.17
Pheton Holdings (PTHL) China $0.121B 0.00
Sera Prognostics (SERA) United States $0.104B 0.00
KindlyMD (NAKA) United States $0.083B 0.00
Ascend Wellness Holdings (AAWH) United States $0.065B 0.00
NeueHealth (NEUE) United States $0.062B 0.00
IceCure Medical (ICCM) Israel $0.055B 0.00
ModivCare (MODV) United States $0.045B 0.00
Biodesix (BDSX) United States $0.041B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.034B 0.00
Basel Medical Group (BMGL) Singapore $0.033B 0.00
OSR Holdings (OSRH) United States $0.027B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
SeaStar Medical Holding (ICU) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00